Anti-PSMA (124)I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle

BACKGROUND: Prostate cancer (PCa) is the second leading cause of cancer-related death in the Western population. The use in oncology of positron emission tomography/computed tomography (PET/CT) with emerging radiopharmaceuticals promises accurate staging of primary disease, restaging of recurrent di...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Exp Clin Cancer Res
Hlavní autoři: Frigerio, B., Morlino, S., Luison, E., Seregni, E., Lorenzoni, A., Satta, A., Valdagni, R., Bogni, A., Chiesa, C., Mira, M., Canevari, S., Alessi, A., Figini, M.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6651934/
https://ncbi.nlm.nih.gov/pubmed/31337429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1325-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky